Investor Overview

NASDAQ: XBIT0.2418.96Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
03/23/17XBiotech Announces Addition of Dr. Dirk Arnold to its Scientific Advisory BoardPrinter Friendly Version
03/09/17XBiotech to Provide Fourth Quarter and Full Year 2016 Business UpdatePrinter Friendly Version
03/03/17XBiotech Announces Registered Direct Offering of Common SharesPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »